Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | MRNA |
---|---|---|
09:32 ET | 67103 | 134.415 |
09:34 ET | 26640 | 133.17 |
09:36 ET | 5598 | 134.29 |
09:38 ET | 8470 | 134.81 |
09:39 ET | 31193 | 134.66 |
09:41 ET | 47320 | 135 |
09:43 ET | 21268 | 135.26 |
09:45 ET | 15544 | 134.885 |
09:48 ET | 12333 | 135.1 |
09:50 ET | 16792 | 136.2 |
09:52 ET | 27290 | 136.39 |
09:54 ET | 8471 | 135.91 |
09:56 ET | 3545 | 135.35 |
09:57 ET | 5717 | 134.875 |
09:59 ET | 9312 | 135.03 |
10:01 ET | 7387 | 135.598 |
10:03 ET | 4551 | 135.41 |
10:06 ET | 2746 | 135.495 |
10:08 ET | 13622 | 135.5053 |
10:10 ET | 2548 | 135.64 |
10:12 ET | 7880 | 136.3 |
10:14 ET | 13740 | 135.465 |
10:15 ET | 1829 | 135.505 |
10:17 ET | 3977 | 135.6408 |
10:19 ET | 5221 | 135.51 |
10:21 ET | 2217 | 135.62 |
10:24 ET | 8247 | 136.457 |
10:26 ET | 8730 | 135.94 |
10:28 ET | 3191 | 135.51 |
10:30 ET | 7088 | 135.66 |
10:32 ET | 6044 | 135.605 |
10:33 ET | 5149 | 135.02 |
10:35 ET | 5269 | 135.22 |
10:37 ET | 2266 | 135.62 |
10:39 ET | 6753 | 135.35 |
10:42 ET | 918 | 135.22 |
10:44 ET | 4346 | 135.57 |
10:46 ET | 11349 | 135.39 |
10:48 ET | 2180 | 135.3716 |
10:50 ET | 3532 | 135.51 |
10:51 ET | 3209 | 135.5817 |
10:53 ET | 6551 | 135.88 |
10:55 ET | 2277 | 135.98 |
10:57 ET | 3716 | 136.12 |
11:00 ET | 8551 | 136.02 |
11:02 ET | 32885 | 136.31 |
11:04 ET | 2287 | 136.25 |
11:06 ET | 3128 | 136.26 |
11:08 ET | 1952 | 136.4499 |
11:09 ET | 3989 | 136.52 |
11:11 ET | 5744 | 136.555 |
11:13 ET | 6280 | 136.81 |
11:15 ET | 5085 | 136.68 |
11:18 ET | 16202 | 136.9 |
11:20 ET | 10773 | 136.9 |
11:22 ET | 2904 | 136.84 |
11:24 ET | 3494 | 136.95 |
11:26 ET | 5524 | 136.61 |
11:27 ET | 7450 | 136.77 |
11:29 ET | 2388 | 136.77 |
11:31 ET | 4085 | 136.86 |
11:33 ET | 19617 | 136.85 |
11:36 ET | 3369 | 136.945 |
11:38 ET | 5462 | 136.955 |
11:40 ET | 6923 | 136.885 |
11:42 ET | 4390 | 136.95 |
11:44 ET | 7664 | 136.74 |
11:45 ET | 11210 | 136.65 |
11:47 ET | 3024 | 136.81 |
11:49 ET | 15204 | 137.37 |
11:51 ET | 7485 | 137.34 |
11:54 ET | 10458 | 137.42 |
11:56 ET | 17710 | 137.415 |
11:58 ET | 2539 | 137.265 |
12:00 ET | 3322 | 137.19 |
12:02 ET | 1968 | 137.28 |
12:03 ET | 1575 | 137.2287 |
12:05 ET | 3335 | 136.972 |
12:07 ET | 1600 | 136.9 |
12:09 ET | 3609 | 136.995 |
12:12 ET | 11260 | 137.21 |
12:14 ET | 6120 | 137.04 |
12:16 ET | 12114 | 136.725 |
12:18 ET | 3108 | 136.7 |
12:20 ET | 3853 | 136.67 |
12:21 ET | 6054 | 136.71 |
12:23 ET | 2557 | 136.93 |
12:25 ET | 2704 | 137.015 |
12:27 ET | 1208 | 137.1 |
12:30 ET | 1985 | 137.06 |
12:32 ET | 3149 | 137.01 |
12:34 ET | 3825 | 136.795 |
12:36 ET | 1210 | 136.71 |
12:38 ET | 1676 | 136.63 |
12:39 ET | 8854 | 136.67 |
12:41 ET | 2910 | 136.665 |
12:43 ET | 1963 | 136.645 |
12:45 ET | 3541 | 136.45 |
12:48 ET | 1200 | 136.42 |
12:50 ET | 4079 | 136.49 |
12:52 ET | 1943 | 136.4 |
12:54 ET | 2055 | 136.26 |
12:56 ET | 6557 | 136.34 |
12:57 ET | 1970 | 136.14 |
12:59 ET | 1381 | 136.11 |
01:01 ET | 4398 | 135.85 |
01:03 ET | 1434 | 135.705 |
01:06 ET | 1996 | 135.72 |
01:08 ET | 6388 | 135.59 |
01:10 ET | 7036 | 135.53 |
01:12 ET | 1879 | 135.85 |
01:14 ET | 2379 | 135.74 |
01:15 ET | 3166 | 135.84 |
01:17 ET | 2299 | 135.99 |
01:19 ET | 1895 | 135.885 |
01:21 ET | 1000 | 135.82 |
01:24 ET | 2154 | 135.64 |
01:26 ET | 2014 | 135.675 |
01:28 ET | 4093 | 135.87 |
01:30 ET | 3446 | 135.92 |
01:32 ET | 2127 | 135.924 |
01:33 ET | 1013 | 135.9 |
01:35 ET | 2729 | 135.7 |
01:37 ET | 5068 | 136.25 |
01:39 ET | 4438 | 136.41 |
01:42 ET | 1869 | 136.135 |
01:44 ET | 1281 | 136.2 |
01:46 ET | 1491 | 136.295 |
01:48 ET | 1079 | 136.47 |
01:50 ET | 2878 | 136.46 |
01:51 ET | 3584 | 136.48 |
01:53 ET | 517 | 136.43 |
01:55 ET | 10654 | 136.43 |
01:57 ET | 3324 | 136.34 |
02:00 ET | 1789 | 136.19 |
02:02 ET | 1527 | 136.19 |
02:04 ET | 2100 | 136.25 |
02:06 ET | 1597 | 136.16 |
02:08 ET | 6829 | 136.47 |
02:09 ET | 7868 | 136.44 |
02:11 ET | 4764 | 136.87 |
02:13 ET | 4218 | 136.93 |
02:15 ET | 2145 | 136.905 |
02:18 ET | 10447 | 136.99 |
02:20 ET | 6886 | 137 |
02:22 ET | 3085 | 136.955 |
02:24 ET | 4444 | 136.9 |
02:26 ET | 4541 | 136.74 |
02:27 ET | 2471 | 136.73 |
02:29 ET | 1912 | 136.93 |
02:31 ET | 7201 | 136.82 |
02:33 ET | 1086 | 136.8975 |
02:36 ET | 1740 | 136.9479 |
02:38 ET | 3269 | 136.9499 |
02:40 ET | 18882 | 136.93 |
02:42 ET | 1826 | 136.83 |
02:44 ET | 15864 | 136.85 |
02:45 ET | 688 | 136.815 |
02:47 ET | 12274 | 137.26 |
02:49 ET | 16638 | 137.02 |
02:51 ET | 5439 | 137.1092 |
02:54 ET | 3384 | 136.977 |
02:56 ET | 676 | 136.85 |
02:58 ET | 3067 | 136.88 |
03:00 ET | 3410 | 136.714 |
03:02 ET | 2519 | 136.6682 |
03:03 ET | 2401 | 136.89 |
03:05 ET | 3830 | 136.95 |
03:07 ET | 1704 | 136.9434 |
03:09 ET | 3981 | 137.01 |
03:12 ET | 2461 | 136.895 |
03:14 ET | 3068 | 137.115 |
03:16 ET | 9735 | 137.205 |
03:18 ET | 12708 | 137.045 |
03:20 ET | 11856 | 137.145 |
03:21 ET | 14231 | 137.14 |
03:23 ET | 5748 | 137.105 |
03:25 ET | 5728 | 136.98 |
03:27 ET | 2007 | 137.05 |
03:30 ET | 4621 | 137.11 |
03:32 ET | 14149 | 137.075 |
03:34 ET | 11582 | 137.075 |
03:36 ET | 4522 | 136.99 |
03:38 ET | 12821 | 136.77 |
03:39 ET | 14134 | 136.77 |
03:41 ET | 11837 | 136.48 |
03:43 ET | 39990 | 136.63 |
03:45 ET | 12757 | 136.735 |
03:48 ET | 11443 | 136.72 |
03:50 ET | 14607 | 136.63 |
03:52 ET | 22856 | 136.83 |
03:54 ET | 23684 | 136.91 |
03:56 ET | 49244 | 137.15 |
03:57 ET | 38391 | 137 |
03:59 ET | 47791 | 137 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Moderna Inc | 51.1B | -8.7x | --- |
ICON PLC | 26.4B | 38.4x | +4.68% |
Biogen Inc | 32.6B | 28.3x | -18.14% |
Biontech SE | 20.1B | 170.3x | --- |
Grifols SA | 6.0B | 23.9x | --- |
Incyte Corp | 14.2B | 19.4x | +39.11% |
Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. Its diverse development pipeline consists of 45 therapeutic and vaccine programs, nine of which are in late-stage development. Its products include COVID-19 vaccines (mRNA-1273/Spikevax, next-generation mRNA-1283), RSV vaccine (mRNA-1345), Seasonal influenza vaccines (mRNA-1010, mRNA-1011, mRNA-1012, mRNA-1020 and mRNA-1030), Combination vaccines (mRNA-1083, mRNA-1230, mRNA-1045 and mRNA-1365), CMV vaccine (mRNA-1647), EBV vaccine (mRNA-1189 and mRNA-1195) and others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $51.1B |
---|---|
Revenue (TTM) | $5.2B |
Shares Outstanding | 383.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.67 |
EPS | $-15.66 |
Book Value | $36.27 |
P/E Ratio | -8.7x |
Price/Sales (TTM) | 9.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -99.73% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.